Cargando…
Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
The immune system plays a critical role in cancer progression and overall survival. Still, it is unclear if differences in the immune response are associated with different patterns of tumor spread apparent in high grade serous ovarian cancer patients and previously described by us. In this study we...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308655/ https://www.ncbi.nlm.nih.gov/pubmed/27665539 http://dx.doi.org/10.18632/oncotarget.11038 |
_version_ | 1782507571057262592 |
---|---|
author | Auer, Katharina Bachmayr-Heyda, Anna Sukhbaatar, Nyamdelger Aust, Stefanie Schmetterer, Klaus G. Meier, Samuel M. Gerner, Christopher Grimm, Christoph Horvat, Reinhard Pils, Dietmar |
author_facet | Auer, Katharina Bachmayr-Heyda, Anna Sukhbaatar, Nyamdelger Aust, Stefanie Schmetterer, Klaus G. Meier, Samuel M. Gerner, Christopher Grimm, Christoph Horvat, Reinhard Pils, Dietmar |
author_sort | Auer, Katharina |
collection | PubMed |
description | The immune system plays a critical role in cancer progression and overall survival. Still, it is unclear if differences in the immune response are associated with different patterns of tumor spread apparent in high grade serous ovarian cancer patients and previously described by us. In this study we aimed to assess the role of the immune system in miliary (widespread, millet-sized lesions) and non-miliary (bigger, exophytically growing implants) tumor spread. To achieve this we comprehensively analyzed tumor tissues, blood, and ascites from 41 patients using immunofluorescence, flow cytometry, RNA sequencing, multiplexed immunoassays, and immunohistochemistry. Results showed that inflammation markers were systemically higher in miliary. In contrast, in non-miliary lymphocyte and monocyte/macrophage infiltration into the ascites was higher as well as the levels of PD-1 expression in tumor associated cytotoxic T-lymphocytes and PD-L1 expression in tumor cells. Furthermore, in ascites of miliary patients more epithelial tumor cells were present compared to non-miliary, possibly due to the active down-regulation of anti-tumor responses by B-cells and regulatory T-cells. Summarizing, adaptive immune responses prevailed in patients with non-miliary spread, whereas in patients with miliary spread a higher involvement of the innate immune system was apparent while adaptive responses were counteracted by immune suppressive cells and factors. |
format | Online Article Text |
id | pubmed-5308655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53086552017-03-09 Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer Auer, Katharina Bachmayr-Heyda, Anna Sukhbaatar, Nyamdelger Aust, Stefanie Schmetterer, Klaus G. Meier, Samuel M. Gerner, Christopher Grimm, Christoph Horvat, Reinhard Pils, Dietmar Oncotarget Research Paper The immune system plays a critical role in cancer progression and overall survival. Still, it is unclear if differences in the immune response are associated with different patterns of tumor spread apparent in high grade serous ovarian cancer patients and previously described by us. In this study we aimed to assess the role of the immune system in miliary (widespread, millet-sized lesions) and non-miliary (bigger, exophytically growing implants) tumor spread. To achieve this we comprehensively analyzed tumor tissues, blood, and ascites from 41 patients using immunofluorescence, flow cytometry, RNA sequencing, multiplexed immunoassays, and immunohistochemistry. Results showed that inflammation markers were systemically higher in miliary. In contrast, in non-miliary lymphocyte and monocyte/macrophage infiltration into the ascites was higher as well as the levels of PD-1 expression in tumor associated cytotoxic T-lymphocytes and PD-L1 expression in tumor cells. Furthermore, in ascites of miliary patients more epithelial tumor cells were present compared to non-miliary, possibly due to the active down-regulation of anti-tumor responses by B-cells and regulatory T-cells. Summarizing, adaptive immune responses prevailed in patients with non-miliary spread, whereas in patients with miliary spread a higher involvement of the innate immune system was apparent while adaptive responses were counteracted by immune suppressive cells and factors. Impact Journals LLC 2016-08-03 /pmc/articles/PMC5308655/ /pubmed/27665539 http://dx.doi.org/10.18632/oncotarget.11038 Text en Copyright: © 2016 Auer et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Auer, Katharina Bachmayr-Heyda, Anna Sukhbaatar, Nyamdelger Aust, Stefanie Schmetterer, Klaus G. Meier, Samuel M. Gerner, Christopher Grimm, Christoph Horvat, Reinhard Pils, Dietmar Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
title | Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
title_full | Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
title_fullStr | Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
title_full_unstemmed | Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
title_short | Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
title_sort | role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308655/ https://www.ncbi.nlm.nih.gov/pubmed/27665539 http://dx.doi.org/10.18632/oncotarget.11038 |
work_keys_str_mv | AT auerkatharina roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT bachmayrheydaanna roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT sukhbaatarnyamdelger roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT auststefanie roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT schmettererklausg roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT meiersamuelm roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT gernerchristopher roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT grimmchristoph roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT horvatreinhard roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer AT pilsdietmar roleoftheimmunesystemintheperitonealtumorspreadofhighgradeserousovariancancer |